Haemonetics Corp. (HAE) Tops Q3 EPS by 7c; Narrows FY11 EPS Outlook
Tweet Send to a Friend
Haemonetics Corp. (NYSE: HAE) reported Q3 EPS of $0.89, $0.07 better than the analyst estimate of $0.82 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
